Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell therapy, raising the efficacy bar in many forms of the disease. But the ...

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic atrophy ...

The fact that the complement system is activated during immune-complex glomerular disease has been known for nearly 50 years. Detection of complement deposition in the glomerulus using immunochemistry ...

Collagen is your body’s most abundant protein, supporting connective tissues like skin, tendons, ligaments, muscles, and bones, but it naturally declines with age. Research suggests collagen ...

Radix Insurance Linked Strategies (Radix ILS), the Bermuda-based third-party capital manager and tech-first reinsurance capacity deployment company, has announced the hiring of Nicolas Plianthos as ...